Amebiasis: clinical and laboratory perspectives.
Entamoeba histolytica, the premier intestinal protozoan, has traversed time in its relentless quest for survival in its dichotomous role of parasite and pathogen. Enigmatic in its transition from human intestinal commensal to invader of human tissue, diverse in its pathogenicity for the human host, and intricate in its bacterial interrelationship in the bowel, E. histolytica has become the focal point of intensive investigation in its basic biology underscoring human pathogenicity. This review will focus on facets of cell biology, pathophysiology, clinical, therapeutic, and epidemiologic, correlates, along with diagnostic modalities and future research trends.
Reitano
M
M
Department of Biology, St. Joseph's College, Patchogue, N.Y.
Masci
J R
JR
Bottone
E J
EJ
D000818:Animals; D004404:Dysentery, Amebic / Q000175:diagnosis / Q000209:etiology; D004748:Entamoeba histolytica / Q000502:physiology; D004749:Entamoebiasis / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D006801:Humans; D008101:Liver Abscess, Amebic / Q000175:diagnosis / Q000209:etiology; D012698:Serologic Tests; D013577:Syndrome